Ixabepilone Administered as an Enteric Coated Formulation.

NCT00309049 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

R-Pharm